Reata Pharmaceuticals Inc

MORGAN STANLEY

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

162,905

Value ($000)

16,610

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	16,610	0.0%	162,905	6/30/2023
2023 Q1	5/15/2023	22,099	0.0%	243,061	3/31/2023
2022 Q4	2/14/2023	27,874	0.0%	733,732	12/31/2022
2022 Q3	11/14/2022	7,873	0.0%	313,242	9/30/2022
2022 Q2	10/27/2022	8,091	0.0%	266,212	6/30/2022
2022 Q1	10/27/2022	10,038	0.0%	306,401	3/31/2022
2021 Q4	2/14/2022	6,924	0.0%	262,597	12/31/2021
2021 Q3	11/15/2021	16,548	0.0%	164,475	9/30/2021
2021 Q2	8/23/2021	9,706	0.0%	68,580	6/30/2021
2021 Q1	5/17/2021	6,220	0.0%	62,387	3/31/2021
2020 Q4	2/16/2021	4,554	0.0%	36,848	12/31/2020
2020 Q3	11/13/2020	3,393	0.0%	34,827	9/30/2020
2020 Q2	8/14/2020	14,086	0.0%	90,293	6/30/2020
2020 Q1	5/26/2020	16,579	0.0%	114,864	3/31/2020
2019 Q4	2/14/2020	11,305	0.0%	55,301	12/31/2019